Union Korea Pharm Revenue

In the year 2025, Union Korea Pharm had annual revenue of 36.38B KRW, down -29.06%. Union Korea Pharm had revenue of 6.48B in the quarter ending December 31, 2025, with 64.76% growth.

Revenue

36.38B

Revenue Growth

-29.06%

P/S Ratio

0.54

Revenue / Employee

219.15M

Employees

166

Market Cap

19.70B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.38B	-14.90B	-29.06%
Dec 31, 2024	51.28B	-11.89B	-18.82%
Dec 31, 2023	63.17B	1.88B	3.06%
Dec 31, 2022	61.29B	12.99B	26.89%
Dec 31, 2021	48.30B	-2.08B	-4.12%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Future Medicine	1.00B
WooGene B&G	54.76B
Kwangdong Healthbio	38.10B
BIFIDO	19.68B
CXI Healthcare Technology Group	54.16B
Hurum	99.01B
Pharmsville	12.73B
Daesung Microbiological Labs.	25.99B

Revenue Rankings